REG - Indivior PLC - Indivior to Participate in Investor Events

IndiviorAnnouncement

06/09/2023 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230906:nRSF6060La&default-theme=true

RNS Number : 6060L  Indivior PLC  06 September 2023

 

 

Indivior To Participate in Upcoming Investor Events

Slough, UK, and Richmond, VA, September 6, 2023 - Indivior PLC (LSE/NASDAQ:
INDV) today announced that it will participate in the following investor
events:

·    Morgan Stanley 21(st) Annual Global Healthcare Conference - New York
City

Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial
Officer, will host 1x1 / group meetings on Monday, September 11(th). Mark
Crossley will participate in a fireside chat at 10:40 a.m. US EDT. Interested
investors should contact their Morgan Stanley representative to schedule a
meeting.  The fireside chat will be publicly available and can be viewed
using the following weblink:

MS Conference Weblink
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcc.webcasts.com%2Fmorg007%2F091123a_js%2F%3Fentity%3D135_YY3QMYJ&data=05%7C01%7Ctimothy.owens%40indivior.com%7C92fd93bed0a34a45532708dba3f1507e%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638284029068560664%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=qoXlZvZRpAnvlkwumZw6IFqs6nUUej441pQUJietA5g%3D&reserved=0)

·    Jefferies Global Healthcare Fireside Chat Series - Virtual

Mark Crossley, Chief Executive Officer, will participate in a fireside chat on
Friday, September 22(nd) at 14:00 BST (9:00 a.m. US EST).  The fireside chat
will be publicly available and can be viewed using the following weblink:

REGISTER
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fjefferies.zoom.us%2Fwebinar%2Fregister%2FWN_iTxWjRBkQfe860MZtv0nvQ&data=05%7C01%7Ctimothy.owens%40indivior.com%7C90a347393b4148c2bbde08dbaa769977%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638291198987884131%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=SoQwfLpLj5uOwJPJURGYdDxLJTwiBsBEp54uizeKO24%3D&reserved=0)

Both events will also be accessible at www.indivior.com
(http://www.indivior.com) under the "Investors" section.

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat addiction and serious mental illnesses.
Our vision is that all patients around the world will have access to
evidence-based treatment for the chronic conditions and co-occurring disorders
of substance use disorder (SUD). Indivior is dedicated to transforming SUD
from a global human crisis to a recognized and treated chronic disease.
Building on its global portfolio of OUD treatments, Indivior has a pipeline of
product candidates designed to both expand on its heritage in this category
and potentially address other chronic conditions and co-occurring disorders of
SUD, including alcohol use disorder and cannabis use disorder. Headquartered
in the United States in Richmond, VA, Indivior employs more than 1,000
individuals globally and its portfolio of products is available in 39
countries worldwide. Visit www.indivior.com (http://www.indivior.com)  to
learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(file:///C:/Users/jthompson/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/VPFVYP6E/www.linkedin.com/company/indivior)
.

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFVVADIRIIV